Quick search:
Result | Content | Outlet | Published | Research |
---|---|---|---|---|
Result | Content | Outlet | Published | Research |
1 | Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study | The Lancet | 5 days ago | |
2 | Why Roe v. Wade must be defended | The Lancet | 3 days ago | |
3 | Cancer in sub-Saharan Africa: a Lancet Oncology Commission | The Lancet | 7 days ago | |
4 | Urban design, transport, and health | The Lancet | 6 days ago | |
5 | Lancet: Alito, Abortion Banners Will Have Women's Blood on Their Hands | Dakota Free Press | 1 day ago | |
6 | Health organizations fear effects of US abortion ruling | The Lancet | 3 days ago | |
7 | Zero COVID in China: what next? | The Lancet | 3 days ago | |
8 | COVID-19: the next phase and beyond | The Lancet | 10 days ago | |
9 | Long COVID: aiming for a consensus | The Lancet | 13 days ago | |
10 | Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase | The Lancet | 7 days ago | |
11 | No area of stroke research should be left behind | The Lancet | 4 days ago | |
12 | Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic | The Lancet | 11 days ago | |
13 | Optimising Child and Adolescent Health and Development | The Lancet | 20 days ago | |
14 | Long-term exposure to wildfires and cancer incidence in Canada: a population-based observational cohort study | The Lancet | 16 days ago | |
15 | Louise Howard: addressing gender gaps in mental health | The Lancet | 2 days ago | |
16 | Correction to Lancet Gastroenterol Hepatol 2022; 7: 513–21 | The Lancet | 16 hours ago | |
17 | AI recognition of patient race in medical imaging: a modelling study | The Lancet | 5 days ago | |
18 | Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study | The Lancet | 24 days ago | |
19 | Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial | The Lancet | 13 days ago | |
20 | COVID-19 pandemic: what's next for public health? | The Lancet | 16 days ago | |
21 | The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial | The Lancet | 3 days ago | |
22 | COVID-19 and inter-generational solidarity | The Lancet | 10 days ago | |
23 | Finding hope in two pandemics | The Lancet | 17 days ago | |
24 | Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study | The Lancet | 25 days ago | |
25 | Calls to restart testing for parasitic disease at US CDC | The Lancet | 3 days ago | |
26 | The Lancet didn't say Covid-19 vaccines are only 1% effective | Full Fact | 6 days ago | |
27 | Tobacco harm reduction matters | The Lancet | 2 days ago | |
28 | Policy stringency and mental health during the COVID-19 pandemic: a longitudinal analysis of data from 15 countries | The Lancet | 26 days ago | |
29 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses | The Lancet | 15 days ago | |
30 | An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial | The Lancet | 20 days ago | |
31 | A collision of pandemics: HIV and COVID-19 | The Lancet | 6 days ago | |
32 | Research Focus: Protas | The Lancet | 24 days ago | |
33 | Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort | The Lancet | 19 days ago | |
34 | The problem of antimicrobial resistance in chronic liver disease | The Lancet | 7 days ago | |
35 | Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial | The Lancet | 24 days ago | |
36 | Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study | The Lancet | 3 days ago | |
37 | The Wuhan lockdown | The Lancet | 5 days ago | |
38 | Doxycycline versus azithromycin for the treatment of anorectal Chlamydia trachomatis infection in women concurrent with vaginal infection (CHLAZIDOXY study): a multicentre, open-label, randomised, controlled, superiority trial | The Lancet | 7 days ago | |
39 | Imagining technologies for disability futures | The Lancet | 10 days ago | |
40 | SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection | The Lancet | 11 days ago | |
41 | Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study | The Lancet | 24 days ago | |
42 | Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial | The Lancet | 22 days ago | |
43 | Improving lithium dose prediction using population pharmacokinetics and pharmacogenomics: a cohort genome-wide association study in Sweden | The Lancet | 8 hours ago | |
44 | Assessment of the 2020 NICE criteria for preoperative radiotherapy in patients with rectal cancer treated by surgery alone in comparison with proven MRI prognostic factors: a retrospective cohort study | The Lancet | 15 days ago | |
45 | Misunderstanding poor adherence to COVID-19 vaccination in Africa | The Lancet | 6 days ago | |
46 | Walking the talk? | The Lancet | 16 days ago | |
47 | US FDA recommends transition to disposable duodenoscopes | The Lancet | 2 days ago | |
48 | Allocated but not treated: the silent 16% | The Lancet | 10 days ago | |
49 | Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review | The Lancet | 3 days ago | |
50 | Only 1/3rd diabetics have blood sugar under control: Lancet study | Hindustan Times | 24 days ago | |
51 | Mediterranean diet prevents repeat heart attacks and strokes, according to Lancet report | Surinenglish.com | 3 days ago | |
52 | Blood Lancet Market Size And Forecast | Becton Dickinson, Improve Medical, Terumo, Sarstedt, Socorex, Graham Field, Paramount Surgimed Ltd, Shangdong Lianfa Medical, PL Medical, Changzhou Kealor – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 3 days ago | |
53 | GRADE misuse in systematic reviews – Authors' reply | The Lancet | 16 days ago | |
54 | Lancet and Pen Needles Market 2022 Growth, Share, [TOP KEY PLAYERS], Business Overview, SWOT Analysis 2030 | Taiwan News | 7 days ago | |
55 | Evolving epidemiology of pneumocystis pneumonia: Findings from a longitudinal population-based study and a retrospective multi-center study in Germany | The Lancet | 2 days ago | |
56 | Lien Jih-ching | The Lancet | 16 days ago | |
57 | Safety Lancet Market 2022 [ADVANTAGES] Size, CAGR Value, and Forecast to 2030 | Dickinson and Company, Terumo Medical Corporation, Bayer AG, HTL-STREFA SA – Queen Anne and Mangolia News | Queen Anne and Mangolia News | 6 days ago | |
58 | Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study | The Lancet | 3 days ago | |
59 | Menopause | The Lancet | 12 days ago | |
60 | 2 years after infection, half of Covid survivors show at least 1 symptom: Lancet study | India Today | 5 days ago | |
61 | Recurrent neural network models (CovRNN) for predicting outcomes of patients with COVID-19 on admission to hospital: model development and validation using electronic health record data | The Lancet | 25 days ago | |
62 | Report of the Lancet Commission on the Value of Death: bringing death back into life | The Lancet | 4 months ago | |
63 | Vaccine for rare but deadly mosquito-borne viruses shows promise in clinical trial | National Institutes of Health (.gov) | 4 days ago | |
64 | Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study | The Lancet | 6 days ago | |
65 | Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 | The Lancet | 3 months ago | |
66 | The Lancet Commission on diagnostics: transforming access to diagnostics | The Lancet | 7 months ago | |
67 | Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission | The Lancet | 3 months ago | |
68 | After the Ockenden review: a chance to reset maternal and perinatal care in the UK? | The Lancet | 7 days ago | |
69 | The Lancet Nigeria Commission: investing in health and the future of the nation | The Lancet | 2 months ago | |
70 | Honiton Museum: The life of Thomas Wakely | Midweek Herald | 3 days ago | |
71 | Time for united action on depression: a Lancet–World Psychiatric Association Commission | The Lancet | 3 months ago | |
72 | Offline: There is no right to lie | The Lancet | 3 months ago | |
73 | Acute onset of fever, eosinophilia, rash, acute kidney injury, and a positive Monospot test in a patient on lamotrigine: DRESS syndrome | The Lancet | 3 days ago | |
74 | The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world | The Lancet | 7 months ago | |
75 | Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts | The Lancet | 3 months ago | |
76 | Highlights 2021: line of sight | The Lancet | 5 months ago | |
77 | Temporal changes of the incidence of childhood cancer in Germany during the COVID-19 pandemic: Updated analyses from the German Childhood Cancer Registry | The Lancet | 4 days ago | |
78 | Offline: A lie at the heart of public health | The Lancet | 3 months ago | |
79 | The Lancet Commission on the future of care and clinical research in autism | The Lancet | 5 months ago | |
80 | Ensuring care for people with depression | The Lancet | 3 months ago | |
81 | Involvement of political and socio-economic factors in the spatial and temporal dynamics of COVID-19 outcomes in Brazil: A population-based study | The Lancet | 2 months ago | |
82 | Offline: COVID-19 as culture war | The Lancet | 4 months ago | |
83 | Series: Heat and health | The Lancet | 9 months ago | |
84 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis | The Lancet | 4 months ago | |
85 | The Lancet Global Health Commission on financing primary health care: putting people at the centre | The Lancet | 1 month ago | |
86 | Is open access a misnomer? | The Lancet | 2 months ago | |
87 | Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial | The Lancet | 7 months ago | |
88 | Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study | The Lancet | 2 months ago | |
89 | The beauty of medical language | The Lancet | 2 months ago | |
90 | Recognising Italy's mistakes in the public health response to COVID-19 | The Lancet | 4 months ago | |
91 | Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 | The Lancet | 2 months ago | |
92 | Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial | The Lancet | 4 months ago | |
93 | Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study | The Lancet | 3 months ago | |
94 | COVID-19 will continue but the end of the pandemic is near | The Lancet | 4 months ago | |
95 | Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study | The Lancet | 4 months ago | |
96 | Risks and burdens of incident diabetes in long COVID: a cohort study | The Lancet | 2 months ago | |
97 | Polish Government COVID-19 advisors resign | The Lancet | 4 months ago | |
98 | First report from the German COVID-19 autopsy registry | The Lancet | 3 months ago | |
99 | Adolescent nutrition | The Lancet | 6 months ago | |
100 | Transitioning to endemicity with COVID-19 research | The Lancet | 3 months ago |